Back

Experience with tecarfarin, a novel vitamin K antagonist: use with reversing agents and in mechanical heart valve recipients

29 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Thrombosis and coagulation Thrombosis and coagulation ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Mark Midei

Armetheon, Monkton (United States of America)

9 More presentations in this session

Presentation thumbnail
Professor M. Ozkan (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Doctor U. Tantry
Abstract Slides
Presentation thumbnail
Doctor X. Li (Princeton, US)
Abstract Slides
Presentation thumbnail
Doctor A. Albertsen (Viborg, DK)
Abstract Slides
Presentation thumbnail
Professor I. Elalamy (Marrakech, MA)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Thrombosis and coagulation

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.
31 August 2019
thumbnail
Webinar
Focus on percutaneous short-term ventricular assist devices: joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices - Part 2. Clinical monitoring and antithrombotic management
22 February 2022
thumbnail
Congress Presentation
Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis
1 September 2020
thumbnail
Congress Presentation
Anticoagulation reversal of dabigatran with idarurizumab in cardiac transplant recipients. More evidence to support its use.
12 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources